These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8713696)

  • 81. Fecal alpha 1-antitrypsin in newborn infants.
    Keller KM; Knobel R; Ewe K
    J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):271-5. PubMed ID: 9138171
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Decreased faecal exoglycosidase activities identify a subset of patients with active Crohn's disease.
    el Yamani J; Mizon C; Capon C; Colombel JF; Fournet B; Cortot A; Mizon J
    Clin Sci (Lond); 1992 Oct; 83(4):409-15. PubMed ID: 1330402
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Screening for cystic fibrosis by analysis of meconium for albumin and protease inhibitors.
    Ryley HC; Neale LM; Brogan TD; Bray PT
    Clin Chim Acta; 1975 Oct; 64(2):117-25. PubMed ID: 1081019
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The forms and the levels of fecal PMN-elastase in patients with colorectal diseases.
    Saitoh O; Sugi K; Matsuse R; Uchida K; Matsumoto H; Nakagawa K; Takada K; Yoshizumi M; Hirata I; Katsu K
    Am J Gastroenterol; 1995 Mar; 90(3):388-93. PubMed ID: 7872275
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Haem in the gut. Part II. Faecal excretion of haem and haem-derived porphyrins and their detection.
    Young GP; St John DJ; Rose IS; Blake D
    J Gastroenterol Hepatol; 1990; 5(2):194-203. PubMed ID: 2103398
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls.
    Bischoff SC; Grabowsky J; Manns MP
    Dig Dis Sci; 1997 Feb; 42(2):394-403. PubMed ID: 9052525
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Fecal alpha 1-antitrypsin and hemoglobin excretion in healthy human milk-, formula-, or cow's milk-fed infants.
    Thomas DW; McGilligan KM; Carlson M; Azen SP; Eisenberg LD; Lieberman HM; Rissman EM
    Pediatrics; 1986 Aug; 78(2):305-12. PubMed ID: 3090512
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Persistence of protein loss in acute diarrhoea. A follow-up study by faecal alpha-1-antitrypsin measurement.
    Zuin G; Fontana M; Nicoli S; Scapellato L; Tamburini G; Gaboardi F
    Acta Paediatr Scand; 1991 Oct; 80(10):961-3. PubMed ID: 1755305
    [No Abstract]   [Full Text] [Related]  

  • 89. Diagnosis of protein-losing enteropathy by gastrointestinal clearance of alpha1-antitrypsin.
    Bernier JJ; Florent C; Desmazures C; Aymes C; L'Hirondel C
    Lancet; 1978 Oct; 2(8093):763-4. PubMed ID: 80688
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparison of the specificity and sensitivity of Hemoccult and HemoQuant in screening for colorectal neoplasia.
    St John DJ; Young GP; McHutchison JG; Deacon MC; Alexeyeff MA
    Ann Intern Med; 1992 Sep; 117(5):376-82. PubMed ID: 1503328
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Intestinal protein loss and hypoalbuminemia in children with pneumonia.
    Klar A; Shoseyov D; Berkun Y; Brand A; Braun J; Shazberg G; Jonathan M; Gross-Kieselstein E; Revel-Vilk S; Hurvitz H
    J Pediatr Gastroenterol Nutr; 2003 Aug; 37(2):120-3. PubMed ID: 12883295
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins.
    Sugi K; Saitoh O; Hirata I; Katsu K
    Am J Gastroenterol; 1996 May; 91(5):927-34. PubMed ID: 8633583
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Fecal alpha 1-antitrypsin excretion in young people with Crohn's disease.
    Thomas DW; Sinatra FR; Merritt RJ
    J Pediatr Gastroenterol Nutr; 1983; 2(3):491-6. PubMed ID: 6604798
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Protein-losing enteropathy in Transkeian children with morbid protein-energy malnutrition.
    Iputo JE
    S Afr Med J; 1993 Aug; 83(8):588-9. PubMed ID: 8211522
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Evaluation of a first-line spectrophotometric screening test for increased faecal porphyrin concentration.
    Zuijderhoudt FM; Dorresteijn-de Bok J; te Velde K
    Eur J Clin Chem Clin Biochem; 1995 May; 33(5):285-8. PubMed ID: 7578607
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Significance of quantitative and qualitative analysis of fecal alpha 1-antitrypsin in gastric cancer patients].
    Sudo I; Miyaoka M; Saito T
    Nihon Shokakibyo Gakkai Zasshi; 1993 Nov; 90(11):2873-81. PubMed ID: 8271459
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Validity of an observational assessment tool for multifaceted evaluation of faecal condition.
    Ohno H; Murakami H; Tanisawa K; Konishi K; Miyachi M
    Sci Rep; 2019 Mar; 9(1):3760. PubMed ID: 30842504
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Laboratory diagnosis of gastrointestinal bleeding.
    Steingold L; Roberts AA
    Gut; 1961 Mar; 2(1):75-81. PubMed ID: 18668740
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Determination of serum antitrypsin in the study of malignant neoplasia.
    WALDVOGEL M; MARVIN HN; WELLS BB
    Proc Soc Exp Biol Med; 1949 Oct; 72(1):100-2. PubMed ID: 15391687
    [No Abstract]   [Full Text] [Related]  

  • 100. Can Alpha-1 Antitrypsin Levels be Used to Predict the Prognosis of COVID-19 Therapy?
    Aras Atik E; Özdemir N; Demirkan K
    Turk J Pharm Sci; 2020 Dec; 17(6):576-577. PubMed ID: 33389945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.